Myopia Treatment Market is expected to reach US$41 billion with a CAGR of nearly 8.40% by the end of 2032.

The global myopia treatment market size was evaluated at US$18 billion in 2023 and is slated to hit US$41 billion by the end of 2032 with a CAGR of nearly 8.40% between 2024 and 2032. The report analyzes the global myopia treatment market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the myopia treatment industry.

Myopia treatment refers to medical and optical methods used to manage nearsightedness, a vision condition in which distant objects appear blurred while nearby objects remain clear due to eye shape changes. Common myopia treatment options include prescription eyeglasses with negative lenses, contact lenses offering a wider visual field, and orthokeratology lenses worn overnight to gently reshape the cornea. Pediatric myopia management often uses low-dose atropine eye drops to slow vision worsening during childhood growth years. Refractive eye surgery options such as LASIK correct myopia by permanently reshaping the cornea using laser technology. Modern myopia control strategies focus on slowing progression rather than only correcting vision clarity. Specialized multifocal eyeglasses and contact lenses manage light focus across the retina to reduce progression speed. Treatment choice depends on age, myopia level, lifestyle needs, progression speed, and patient comfort. Regular eye examinations ensure proper adjustment of myopia treatment plans. Combination approaches often provide better long-term myopia management outcomes.

Browse the full “Myopia Treatment Market By Treatment Type (Vision Therapy, Glasses, Refractive Surgery, Ortho-K, Contact Lenses, and Myopia Control Eye Drops), By End-User (Specialty Clinics, Refractive Surgery Centers, and Hospitals & Clinics), By Age Group (Adult Myopia and Childhood Myopia) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032​" Report at https://www.zionmarketresearch.com/report/myopia-treatment-market

The growth of the global myopia treatment industry is growing primarily due to rising myopia rates among children and young adults, increased screen time contributing to vision problems, and growing awareness of myopia control therapies that prevent severe nearsightedness complications.

Market Growth Factors

Several factors are propelling the expansion of the myopia treatment market.

• Childhood myopia epidemic: Increasing nearsightedness among school children drives strong demand for early treatment, as parents and doctors focus on preventing severe myopia and long-term eye complications.
• Digital device usage increases: Extensive use of smartphones, tablets, and computers for learning and entertainment raises myopia risk, encouraging families to seek corrective solutions and specialized eye care support.
• Myopia control awareness expansion: Better understanding of myopia progression among eye care professionals promotes early intervention strategies focused on slowing vision deterioration and protecting long-term eye health.

Restraints

• Treatment cost barriers: Advanced myopia control treatments, such as orthokeratology lenses and multifocal contact lenses, remain costly, limiting access for families without sufficient financial resources or insurance coverage.
• Patient compliance challenges: Daily atropine drops and overnight lens use require strict routines, which some children find difficult to follow consistently over long treatment periods.

Market Segmentation

The myopia treatment market can be segmented by treatment type, patient age group, distribution channel, end-user, and region.

Based on treatment type, the myopia treatment industry is segmented into eyeglasses, contact lenses, atropine therapy, orthokeratology, refractive surgery, and myopia control lenses. Contact lenses are expected to maintain a significant market share during the forecast period due to their popularity among teenagers and adults seeking vision correction without visible eyewear.

Based on patient age group, the myopia treatment market is classified into children aged 6 to 12 years, teenagers aged 13 to 18 years, young adults aged 19 to 35 years, and adults above 35 years. Teenagers are expected to lead the market during the forecast period due to high myopia prevalence and strong treatment uptake.

Based on distribution channel, the market is categorized into optical retail chains, independent optometry practices, hospital ophthalmology departments, online eyewear retailers, and vision care centers. Optical retail chains lead the market due to convenient locations and comprehensive service offerings, including eye exams and product selection.

Based on end user, the market is divided into individual consumers, educational institutions, corporate vision programs, and healthcare facilities. Individual consumers lead the market as primary purchasers of corrective eyewear and recipients of professional eye care services.

Asia Pacific represents the leading myopia treatment market due to extremely high nearsightedness prevalence across children, adolescents, and young adults in many countries. East Asian nations report very high myopia rates driven by intensive education systems, extended study hours, and limited outdoor activity. Widespread use of digital devices for education and entertainment further increases vision strain among school-age populations. Large regional populations convert high prevalence into millions of patients requiring continuous vision correction and myopia control solutions. Rising middle-class income levels allow families to afford advanced treatments such as atropine therapy, orthokeratology, and multifocal lenses. Government-supported eye health programs promote early screening, school-based vision checks, and public education on myopia prevention. Continuous innovation and awareness position Asia Pacific as a global hub for myopia treatment growth.

Key Market Players

Leading companies operating in the global myopia treatment market include:

• Haag-Streit Holding
• Bausch Health Companies Inc.
• Carl Zeiss AG
• Alcon
• Sydnexis Inc.
• Johnson & Johnson Vision
• AbbVie
• CooperVision Topcon Corporation
• NIDEK CO. LTD
• Essilor Ltd.
• Ziemer Ophthalmic Systems AG
• Regeneron Pharmaceuticals Inc.
• Eyenovia Inc.

Recent Developments

• In July 2025, ENTOD Pharmaceuticals secured approval from India’s Central Drugs Standard Control Organization for 0.05% atropine eye drops (Myatro XL) designed to slow myopia progression in children aged 6–12 years, strengthening pediatric myopia treatment options.

The global myopia treatment market is segmented as follows:

By Treatment Type

• Vision Therapy
• Glasses
• Refractive Surgery
•  Ortho-K
• Contact Lenses
•  Myopia Control Eye Drops

By End-User

• Specialty Clinics
• Refractive Surgery Centers
• Hospitals & Clinics

By Age Group

• Adult Myopia
•  Childhood Myopia

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com